Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
Sophie Lehn(Lund University), Göran Landberg(University of Gothenburg)
Cited by 44
Related Papers
Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
|British Journal of Cancer|2009|168
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
|British Journal of Cancer|2004|166
Cyclin D1, Id1 and EMT in breast cancer
|BMC Cancer|2011|145
Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration
|PLoS ONE|2012|89
Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion
|Breast Cancer Research|2018|76